Xiaobin Yang

612 total citations
28 papers, 470 citations indexed

About

Xiaobin Yang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xiaobin Yang has authored 28 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Xiaobin Yang's work include Bone Metabolism and Diseases (16 papers), Bone health and treatments (7 papers) and Spine and Intervertebral Disc Pathology (4 papers). Xiaobin Yang is often cited by papers focused on Bone Metabolism and Diseases (16 papers), Bone health and treatments (7 papers) and Spine and Intervertebral Disc Pathology (4 papers). Xiaobin Yang collaborates with scholars based in China, United States and United Kingdom. Xiaobin Yang's co-authors include Lingbo Kong, Baorong He, Biao Wang, Dingjun Hao, Wanli W. Smith, Chengchao Song, Jinglong Yan, Zhen Zhang, Liang Yan and Hua Guo and has published in prestigious journals such as Chemical Engineering Journal, Spine and European Journal of Pharmacology.

In The Last Decade

Xiaobin Yang

28 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobin Yang China 12 314 113 94 57 56 28 470
Xiangde Zhao China 12 310 1.0× 99 0.9× 108 1.1× 60 1.1× 42 0.8× 18 423
Dongfeng Zhao China 14 531 1.7× 106 0.9× 52 0.6× 38 0.7× 58 1.0× 22 677
Jianbo Fan China 15 366 1.2× 76 0.7× 207 2.2× 53 0.9× 49 0.9× 34 568
Weihang Gao China 9 413 1.3× 55 0.5× 138 1.5× 46 0.8× 77 1.4× 15 636
Yongtao Geng China 8 401 1.3× 100 0.9× 161 1.7× 63 1.1× 69 1.2× 9 586
Yu‐Mi Yang South Korea 12 376 1.2× 105 0.9× 55 0.6× 54 0.9× 59 1.1× 21 581
Won‐Gu Jang South Korea 13 312 1.0× 49 0.4× 126 1.3× 37 0.6× 35 0.6× 35 531

Countries citing papers authored by Xiaobin Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Yang more than expected).

Fields of papers citing papers by Xiaobin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Yang. The network helps show where Xiaobin Yang may publish in the future.

Co-authorship network of co-authors of Xiaobin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Yang. A scholar is included among the top collaborators of Xiaobin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Yang. Xiaobin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Hongzhi, Fan Su, Chen Liu, et al.. (2025). Quorum sensing enhances microbial resistance to substrate toxicity during anaerobic caproate production. Chemical Engineering Journal. 520. 166049–166049. 1 indexed citations
2.
Huang, Yunfei, Bo Yang, Baorong He, et al.. (2023). Nicotinamide mononucleotide supplementation mitigates osteopenia induced by modeled microgravity in rats. Cell Stress and Chaperones. 28(4). 385–394. 3 indexed citations
3.
Yang, Xiaobin, et al.. (2021). The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance. Current Medicinal Chemistry. 28(25). 5228–5247. 6 indexed citations
4.
Yang, Xiaobin, et al.. (2021). Effects of the Tight Junction Protein CLDN6 on Cell Migration and Invasion in High-Grade Meningioma. World Neurosurgery. 151. e208–e216. 9 indexed citations
5.
Yang, Xiaobin, et al.. (2020). The Regulation of E3 Ubiquitin Ligases Cbl and its Cross-talking in Bone Homeostasis. Current Stem Cell Research & Therapy. 16(6). 683–687. 2 indexed citations
6.
Yang, Xiaobin, et al.. (2020). Quantification evaluation of structural autograft versus morcellized fragments autograft in patients who underwent single‑level lumbar laminectomy. Experimental and Therapeutic Medicine. 20(2). 1803–1807. 1 indexed citations
7.
8.
Lyu, Qian, Jin Li, Xiaobin Yang, & Fang Zhang. (2019). LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma. Pathology - Research and Practice. 215(5). 924–930. 31 indexed citations
9.
Wang, Youhan, Biao Wang, & Xiaobin Yang. (2019). The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide’s Toxicity. Current Stem Cell Research & Therapy. 15(1). 18–23. 13 indexed citations
10.
He, Baorong, et al.. (2019). Puerarin for OVX-Induced Postmenopausal Osteoporosis in Murine Model: Systematic Review and Meta-Analysis. Current Stem Cell Research & Therapy. 15(1). 37–42. 7 indexed citations
11.
Zhang, Ke, Jun Lei, Yuan He, et al.. (2018). A flavonoids compound inhibits osteoclast differentiation by attenuating RANKL induced NFATc-1/c-Fos induction. International Immunopharmacology. 61. 150–155. 12 indexed citations
12.
Song, Chengchao, Xiaobin Yang, Zhen Zhang, et al.. (2018). Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. Journal of Cellular Physiology. 234(7). 11969–11975. 108 indexed citations
13.
Jiang, Yonghong, Baorong He, Hao Wen, et al.. (2018). Mini-review: Functions and Action Mechanisms of PQQ in Osteoporosis and Neuro Injury. Current Stem Cell Research & Therapy. 15(1). 32–36. 9 indexed citations
14.
Li, Longmei, Sumei Wang, Xiaobin Yang, et al.. (2017). Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway. Molecular Medicine Reports. 16(3). 2461–2468. 23 indexed citations
15.
Kong, Lingbo, Rui Ma, Xiaobin Yang, et al.. (2017). Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines. International Immunopharmacology. 51. 31–39. 42 indexed citations
16.
Kong, Lingbo, Biao Wang, Xiaobin Yang, et al.. (2017). Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production. Cellular Physiology and Biochemistry. 43(4). 1425–1435. 31 indexed citations
17.
Yang, Xiaobin, Wenjie Gao, Biao Wang, et al.. (2017). Picroside II Inhibits RANKL‐Mediated Osteoclastogenesis by Attenuating the NF‐κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice. Journal of Cellular Biochemistry. 118(12). 4479–4486. 17 indexed citations
18.
Yang, Xiaobin, et al.. (2016). Treatment with hydrogen sulfide attenuates sublesional skeletal deterioration following motor complete spinal cord injury in rats. Osteoporosis International. 28(2). 687–695. 20 indexed citations
19.
Yang, Xiaobin, et al.. (2015). Treating Huge Tear-Drop Fracture of Axis With Trapezoidal Bone. Spine. 40(22). E1187–E1190. 5 indexed citations
20.
Yang, Xiaobin, Baorong He, Peng Liu, et al.. (2015). Treatment with curcumin alleviates sublesional bone loss following spinal cord injury in rats. European Journal of Pharmacology. 765. 209–216. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026